ALR Technologies Inc.
3350 Riverwood Pkwy
59 articles with ALR Technologies Inc.
ALR Technologies Announces Formation of an Animal Health DivisionLaunching the FIRST and ONLY Continuous Glucose Monitor (“CGM”) for Diabetic Companion Animals
ALR Technologies SG Pte. Ltd., the diabetes management company, announces the establishment of the ALRT Animal Health Division, a new business division which will introduce the world’s FIRST and ONLY CGM for diabetic companion animals.
ALR Technologies Inc. announced that it is taking steps to redomicile the Company to Singapore.
ALRT Diabetes Solution Platform is Cleared by Health CanadaThe ALRT Diabetes Solution software received Medical Device Establishment Licence (MDEL) – MDEL 15143 (Company ID 161989)
ALR Technologies Inc., the diabetes management company, is pleased to announce the clearance of the ALRT Diabetes Solution software by Health Canada.
ALR Technologies SG Pte. Ltd (“ALRT”) and Diabetes Singapore Execute a Memorandum of Understanding to Form a CollaborationThe program will expand the availability of the ALRT Diabetes Solution to Singapore Residents
ALR Technologies Inc. (“ALRT”) (OTCQB: ALRT), is pleased to announce that its wholly owned subsidiary ALR Technologies SG Pte. Ltd has executed a Memorandum of Understanding (MOU) with Diabetes Singapore , a full member in the International Diabetes Federation (IDF). The MOU outlines a collaboration between the two parties to raise the diabetes management standard in Singapore. The collaboration intends to develop a diabetes management program
ALRT Launches Prediabetes Solution Completing Most Comprehensive Diabetes Management System Available TodayNew Feature Will Expand the Scope of the ALRT Diabetes Solution to Help Prevent Diabetes
ALR Technologies Inc. (OTCQB: ALRT) is launching the ALRT Prediabetes Solution. This is a new, prevention-based feature of the ALRT Diabetes Solution that is already well-positioned in the diabetes patient care marketplace. The new product was designed in direct response to discussions with government healthcare authorities for a scalable solution that could address the growing problem of prediabetes. ALRT is making its new Prediabetes Solutio
ALR Technologies Inc. (“ALRT”) Launches ALRT Diabetes Solution in Private Practice Physician Clinics across Singapore
ALRT Partners with Bionime Corporation to Offer Comprehensive Diabetes Solution at Lower Cost Than Test Supplies Alone Available in Pharmacy Chains
ALR Technologies Partners with Centrus Health Clinics to Conduct a Clinical PilotALRT will demonstrate proof of its remote diabetes patient management concept in partnership with Clinics of Centrus Health Kansas City
ALR Technologies, Inc. (“ALRT”) (OTCQB: ALRT), the diabetes management company, has signed agreements with clinics of Centrus Health Kansas City to conduct a clinical pilot. Four Centrus Health Kansas City primary care clinics will participate in the pilot: AdventHealth Medical Group, Clay-Platte Family Medicine Clinic, Northland Family Care and one other clinic. The pilot will demonstrate the clinical usefulness of the ALRT Diabetes Solution i
ALR Technologies Inc. Announces Commencement of OTCQB Trading ALRT has been approved to upgrade the trading of its common stock to the OTCQB Venture Market
ALR Technologies Inc. (“ALRT” or the “Company”) (OTCQB: ALRT), the diabetes management company, is pleased to announce that its common shares are now trading on the OTCQB Venture Market. We believe that graduating to the OTCQB Venture Market is an important step for the company’s future and that it will bring better visibility and liquidity within the investment community. The OTCQB Venture Market is well suited for developing companies. To b
ALR Technologies Announces their ALRT Diabetes Solution Provides Telehealth Service Opportunities for Physicians and their Patients The Coronavirus (COVID-19) pandemic highlights the need for and benefits of Telehealth
ALR Technologies, Inc. announces their ALRT Diabetes Solution platform provides the tools physicians need to offer telehealth, telemedicine, and remote patient monitoring services to their patients with diabetes. The expanded reimbursements for telehealth services, recently announced by the Centers for Medicare and Medicaid Services (CMS) due to the coronavirus outbreak, is especially h
ALR Technologies Inc. Announces Corporate Updates ALRT has applied to OTC Markets to upgrade the trading of its common stock to the OTCQB Venture Market and has had its common stock approved for DWAC FAST
ALR Technologies Inc. (“ALRT” or the “Company”)(OTCPINK: ALRT), the diabetes management company, has been approved for its common stock to be DWAC FAST and has submitted an application to upgrade the trading of its common stock to the OTCQB ® Venture Market. OTCQB Trading Application The Company is pleased to announce that it has applied to the OTC Markets Group Inc. to upgrade trading from the Pink Market to the OTCQB Venture Market.
ALRT will demonstrate proof of its remote diabetes patient management concept in partnership with Singapore General Hospital
ALR Technologies Inc. Release: ALRT System Significantly Lowers A1C Levels In Type 2 Diabetes Patients In Real World Pilot Program
ALR Technologies Inc. Seeks FDA Approval For Insulin Dose Adjustment Feature For Better Diabetes Management
ALR Technologies Inc. Advocates For Sensible Medicare Reimbursement Of Continuous Glucose Monitoring (CGM) For Diabetes Patients
ALR Technologies Inc. To Conduct Clinical Trial With Premier Hospital Of Chilean Health Ministry In Santiago